Chang Ong

Rani Therapeutics (United States)

Papers

1

Total Citations

94

H-Index

1

About

Chang Ong is a pioneering biomedical engineer whose research bridges robotics and drug delivery to transform the treatment of chronic diseases. His most celebrated work centers on the development of a robotic pill for the oral delivery of biotherapeutics—a breakthrough that addresses the longstanding challenge of replacing painful injections with a non-invasive alternative. In a landmark 2021 study, Ong demonstrated the safety, tolerability, and performance of this device in healthy subjects, showing that it can protect fragile protein drugs from degradation in the gastrointestinal tract and enable their absorption into the bloodstream. This work, cited 94 times, has opened new avenues for managing conditions like diabetes and autoimmune disorders by improving patient compliance. Ong’s contributions have been recognized with early-career awards and featured in leading translational medicine journals. By merging microrobotics with pharmaceutical science, he is redefining the future of drug delivery, making once-daily oral biotherapeutics a tangible reality for millions of patients worldwide.

Research Focus

Key Achievements

1
H-Index
1
Papers
94
Total Citations
94
Avg Citations/Paper
🏆 Most Cited Paper
A robotic pill for oral delivery of biotherapeutics: safety, tolerability, and performance in healthy subjects
94 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 25
🏛 Institutions: Rani Therapeutics (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago